GlassScriptPhysician profile
Amanda Rodriguez
NPI 1477983674
$346.10
in general payments reported to CMS, 2019-2025
11 companies · $83.10 in 2025
The $83.10 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.27 · 2023: $15.50 · 2024: $200 · 2025: $83.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $124.94 | 2024 | Voquezna |
| Acadia Pharmaceuticals INC | $32.47 | 2025 | Daybue |
| Astellas Pharma US INC | $30.34 | 2022-2024 | Cresemba |
| Horizon Therapeutics Plc | $27.90 | 2022-2023 | Krystexxa |
| Sanofi Pasteur INC. | $23.22 | 2022 | |
| Merck Sharp & Dohme LLC | $21.47 | 2024 | Rotateq, Vaxelis, M-M-R II |
| Pfizer INC. | $20.96 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $18.54 | 2025 | Zoryve |
| Novo Nordisk INC | $18.03 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $14.17 | 2024 | Airsupra |
| Axsome Therapeutics, INC. | $14.06 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.